Outlook Therapeutics, Inc. (OTLK) › EPS (Diluted)Outlook Therapeutics, Inc. (OTLK) — EPS (Diluted)Annual figures by fiscal year, from SEC filings.2016: $-3.672017: $-1.802018: $-1.222020: $-0.672021: $-0.352022: $-0.312023: $-4.722024: $-4.062025: $-1.79$-1.792016EPS (Diluted) (USD/shares)2025Fiscal YearEPS (Diluted)Change YoY2025$-1.79+55.9%2024$-4.06+14.0%2023$-4.72-1422.6%2022$-0.31+11.4%2021$-0.35+47.8%2020$-0.67—2018$-1.22+32.2%2017$-1.80+51.0%2016$-3.67—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeTotal AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share